80 related articles for article (PubMed ID: 16387340)
1. Waiting times for the appearance of cytotoxic T-lymphocyte escape mutants in chronic HIV-1 infection.
Liu Y; Mullins JI; Mittler JE
Virology; 2006 Mar; 347(1):140-6. PubMed ID: 16387340
[TBL] [Abstract][Full Text] [Related]
2. Multiple HIV-1 infection of cells and the evolutionary dynamics of cytotoxic T lymphocyte escape mutants.
Wodarz D; Levy DN
Evolution; 2009 Sep; 63(9):2326-39. PubMed ID: 19486149
[TBL] [Abstract][Full Text] [Related]
3. CTL escape and increased viremia irrespective of HIV-specific CD4+ T-helper responses in two HIV-infected individuals.
Geels MJ; Jansen CA; Baan E; De Cuyper IM; van Schijndel GJ; Schuitemaker H; Goudsmit J; Pollakis G; Miedema F; Paxton WA; van Baarle D
Virology; 2006 Feb; 345(1):209-19. PubMed ID: 16246391
[TBL] [Abstract][Full Text] [Related]
4. Unique acquisition of cytotoxic T-lymphocyte escape mutants in infant human immunodeficiency virus type 1 infection.
Pillay T; Zhang HT; Drijfhout JW; Robinson N; Brown H; Khan M; Moodley J; Adhikari M; Pfafferott K; Feeney ME; St John A; Holmes EC; Coovadia HM; Klenerman P; Goulder PJ; Phillips RE
J Virol; 2005 Sep; 79(18):12100-5. PubMed ID: 16140787
[TBL] [Abstract][Full Text] [Related]
5. Multiple transmissions of a stable human leucocyte antigen-B27 cytotoxic T-cell-escape strain of HIV-1 in The Netherlands.
Cornelissen M; Hoogland FM; Back NK; Jurriaans S; Zorgdrager F; Bakker M; Brinkman K; Prins M; van der Kuyl AC
AIDS; 2009 Jul; 23(12):1495-500. PubMed ID: 19487902
[TBL] [Abstract][Full Text] [Related]
6. Rates of HIV immune escape and reversion: implications for vaccination.
Davenport MP; Loh L; Petravic J; Kent SJ
Trends Microbiol; 2008 Dec; 16(12):561-6. PubMed ID: 18964018
[TBL] [Abstract][Full Text] [Related]
7. Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection.
Brumme ZL; Tao I; Szeto S; Brumme CJ; Carlson JM; Chan D; Kadie C; Frahm N; Brander C; Walker B; Heckerman D; Harrigan PR
AIDS; 2008 Jul; 22(11):1277-86. PubMed ID: 18580606
[TBL] [Abstract][Full Text] [Related]
8. HIV CTL escape: at what cost?
Smith SM
Retrovirology; 2004 May; 1():8. PubMed ID: 15169568
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of HIV-1-specific CD8 T-cell responses and their role in loss of viremia in children chronically infected with HIV-1 undergoing highly active antiretroviral therapy.
Zhang Z; Zhao QX; Fu JL; Yao JX; He Y; Jin L; Wang FS
Chin Med J (Engl); 2006 Dec; 119(23):1949-57. PubMed ID: 17199938
[TBL] [Abstract][Full Text] [Related]
10. The rate of immune escape vanishes when multiple immune responses control an HIV infection.
van Deutekom HW; Wijnker G; de Boer RJ
J Immunol; 2013 Sep; 191(6):3277-86. PubMed ID: 23940274
[TBL] [Abstract][Full Text] [Related]
11. A condition for successful escape of a mutant after primary HIV infection.
Monteiro LH; Gonçalves CH; Piqueira JR
J Theor Biol; 2000 Apr; 203(4):399-406. PubMed ID: 10736216
[TBL] [Abstract][Full Text] [Related]
12. Founder effects in the assessment of HIV polymorphisms and HLA allele associations.
Bhattacharya T; Daniels M; Heckerman D; Foley B; Frahm N; Kadie C; Carlson J; Yusim K; McMahon B; Gaschen B; Mallal S; Mullins JI; Nickle DC; Herbeck J; Rousseau C; Learn GH; Miura T; Brander C; Walker B; Korber B
Science; 2007 Mar; 315(5818):1583-6. PubMed ID: 17363674
[TBL] [Abstract][Full Text] [Related]
13. Assessing the antiviral activity of HIV-1-specific cytotoxic T lymphocytes.
Yang OO
Methods Mol Biol; 2009; 485():407-15. PubMed ID: 19020840
[TBL] [Abstract][Full Text] [Related]
14. Time Intervals in Sequence Sampling, Not Data Modifications, Have a Major Impact on Estimates of HIV Escape Rates.
Ganusov VV
Viruses; 2018 Feb; 10(3):. PubMed ID: 29495443
[TBL] [Abstract][Full Text] [Related]
15. Sequence conservation of subdominant HLA-A2-binding CTL epitopes in HIV-1 clinical isolates and CD8+ T-lymphocyte cross-recognition may explain the immune reaction in infected individuals.
Thorn M; Tang S; Therrien D; Kløverpris H; Vinner L; Kronborg G; Gerstoft J; Corbet S; Fomsgaard A
APMIS; 2007 Jun; 115(6):757-68. PubMed ID: 17550385
[TBL] [Abstract][Full Text] [Related]
16. Peptide-loaded dendritic-cell vaccination followed by treatment interruption for chronic HIV-1 infection: a phase 1 trial.
Ide F; Nakamura T; Tomizawa M; Kawana-Tachikawa A; Odawara T; Hosoya N; Iwamoto A
J Med Virol; 2006 Jun; 78(6):711-8. PubMed ID: 16628588
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of HIV-1 CD8+ T cell escape variants with impaired fitness.
Sanchez-Merino V; Farrow MA; Brewster F; Somasundaran M; Luzuriaga K
J Infect Dis; 2008 Jan; 197(2):300-8. PubMed ID: 18177249
[TBL] [Abstract][Full Text] [Related]
18. Impaired immune evasion in HIV through intracellular delays and multiple infection of cells.
Althaus CL; De Boer RJ
Proc Biol Sci; 2012 Aug; 279(1740):3003-10. PubMed ID: 22492063
[TBL] [Abstract][Full Text] [Related]
19. Anti-HIV adaptive immunity: determinants for viral persistence.
Yamamoto H; Matano T
Rev Med Virol; 2008; 18(5):293-303. PubMed ID: 18416450
[TBL] [Abstract][Full Text] [Related]
20. Defective escape mutants of HIV.
Berry RM; Nowak MA
J Theor Biol; 1994 Dec; 171(4):387-95. PubMed ID: 7869736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
